CABIO 嘉必优 (SSE 688089)
曾用名: Alking Bioengineering
嘉必优生物技术(武汉)股份有限公司是一家食品生产企业,位于中国湖北省武汉市东湖新技术开发区高新大道999号。
简介
CABIO Biotech (Wuhan) Co., Ltd. (SSE: 688089) is a high-tech biotechnology company specializing in the research, production, and sale of high-value nutritional ingredients using synthetic biology and microbial fermentation. Founded in September 2004 and headquartered in Wuhan, China, it is the first company from Hubei Province to list on the STAR Market.
Core products include polyunsaturated fatty acids (ARA, DHA), terpenoids (β-carotene, astaxanthin), and carbohydrates (sialic acid, HMOs). These are used in infant formula, dietary supplements, animal nutrition, and personal care.
The company is active and growing, with 2025 reports highlighting its “one core, two wings” strategy (human nutrition, animal nutrition, and personal care). It maintains long-term partnerships with global firms like Cargill, Danone, Nestlé, and major Chinese dairy companies. As of late 2024, it operates significant fermentation and microencapsulation capacity, with ARA and DHA oil capacities exceeding 600 tons each. The company is controlled by Wuhan Xiwang Bioengineering Co., Ltd., with Yi Dewei serving as the actual controller.
Sources#
供应的生物解决方案 2
产品与服务
产品: 嘉必优®ARA;嘉必优®DHA藻油;嘉必优β-胡萝卜素;嘉必优 燕窝酸;ARA oil;DHA oil;Peanut Arachidonic Acid(ARA);Docosahexaenoic Acid(DHA);Beta-Carotene(BC);N-Acetyl Neuraminic Acid
认证: ISO 9001; FSSC22000; FDA GRAS; EU Novelfood; Clean Production Certification; Energy Management System Certification; Green Factory Certification
生产与研发基地 9
- Wuhan, China Various biosynthetic products
- Gedian Factory Various microbial fermentation products
- Jiangxia Factory Various microbial fermentation products
- Jiawei Factory Various microbial fermentation products
- Hubei Wuhan, Jiangxia District, Wuhan Synthetic Biological Innovation Center
- Hubei Wuhan, Jiangxia District, Wuhan Pharmaceutical Industry Park
- Hubei Gedian Development Zone
- Jiangxia
- Gedian
依据企业公开披露与合规登记汇总的核心生产基地、中试车间与研发中心分布。
- 应用
- Human Nutrition · Animal Nutrition · Personal Care · Synthetic Biology · 人类营养 · 动物营养 · 个人护理 · 合成生物学
- 认证(官网)
- ISO 9001 · FSSC22000 · FDA GRAS · EU Novelfood · Clean Production Certification · Energy Management System Certification · Green Factory Certification
- 客户与合作伙伴
- 行业人才培养 · 公众营养健康认知提升 · Over 300 global partners.
- 产品(官网)
- 嘉必优®ARA — A ω-6 polyunsaturated fatty acid obtained through biosynthesis technology, essential for human growth and development. It is the first in China to pass EU Novelfood and US FDA GRAs review. · 嘉必优®DHA藻油 — A ω-3 polyunsaturated fatty acid synthesized from single-cell algae, produced in a closed, clean environment. It has passed US FDA GRAS review and offers advantages of controlled quality and sustainability. · 嘉必优β-胡萝卜素 — A high-purity carotenoid product obtained through biosynthesis, providing a good solution for natural colorants and food ingredients. · 嘉必优 燕窝酸 — Also known as N-acetylneuraminic acid, a characteristic component of traditional bird's nest supplements. It is produced in collaboration with the Chinese Academy of Sciences and has good application prospects in infant formula, health foods, and cosmetics. · ARA oil — Product certified with carbon footprint certificate. · DHA oil — Product certified with environmental declaration certificate and third-party verification report. · Peanut Arachidonic Acid (ARA) · Docosahexaenoic Acid (DHA) · Beta-Carotene (BC) · N-Acetyl Neuraminic Acid · 嘉必优®ARA — Meets infant nutritional needs · 嘉必优DHA系列产品 — Supports brain development in early life
- 研发设施
- Synthetic Biology Laboratory
摘自公司官网: about · products · production · quality · rnd · contact · sustainability · topic
子公司: 嘉利多生物技术(武汉)有限公司 (controlled by CABIO) · 中科光谷公司 (wholly owned by CABIO)
状态
近期新闻 5
精选自公开商业披露与权威行业资讯。引用或用于商业决策前,请以官方原文公告为准。
- 2026-09-30 嘉必优生物技术(武汉)股份有限公司关于公司股票被实施其他风险警示的进展公告|上海证券报 paper.cnstock.comCABIO 嘉必优生物技术(武汉)股份有限公司被科创板实施“其他风险警示”自2026-07-28起,原因是其生产经营受到严重影响且预计3个月内无法恢复;公司正在推进多项措施改善供应链、提升产能、拓展人类与动物营养、以及HMOs等产研方向,月披露进展,若全年收入低于1亿元存在退市风险。
- 2026-07-27 嘉必优中报预亏过亿、明日起“戴帽”,海外双重冲击重创这家全球第二ARA龙头-钛媒体官方网站 tmtpost.comCABIO 嘉必优 (688089.SH) 正面临严重经营危机:因海外市场监管与新要求影响,上半年营收骤降82%且预计亏损1.01亿元,若全年营收低于1亿元将被ST处理,海外ARA业务受欧盟严格检测与通关新规冲击,可能导致退市风险与生死线压力增大。
- 2026-01-30 中生技公司“嘉必优”成为奶粉下架的焦点 - RFI - 法国国际广播电台 rfi.frCABIO 嘉必优生物科技是一家中国公司,声称为Dano/雀巢等客户提供富含ARA的油脂,并逐渐成为全球此类原料供应的重要玩家;目前涉嫌与一批婴儿配方奶粉中毒素污染案相关联,成为媒体关注的焦点,但官方未点名其为供货源,且公司尚未就事件作出公开回应。
- 2026-01-27 嘉必优陷雀巢奶粉召回风波,外媒指原料污染源头为中国供应商_腾讯新闻 news.qq.comCABIO 嘉必优 is under intense scrutiny in connection with a whey/ARA (arachidonic acid) raw material contamination linked to Nestlé’s recall; Swiss authorities and media imply the supplier was CABIO, and the company has not publicly confirmed or explained its role, fueling market …
- 2026-01-08 各大乳企紧急与陷入雀巢召回事件的供应商嘉必优切割|界面新闻 jiemian.comCABIO 嘉必优 is a major but not indispensable supplier of ARA for top infant formula makers; the Nestlé recall incident underscores a potential vulnerability, as processors can replace its ARA, and CABIO’s share of the ARA market (about 70% of its revenue) faces reputational and …
关系网络:股东、合作伙伴、同类
股权与投资方 2
| 子公司 | 嘉利多生物技术(武汉)有限公司 |
| 子公司 | 中科光谷公司 |
同类企业
LinYi YouKang Biology Co.,Ltd · FERMENTALG · Qingdao ZolanBio Co., Ltd · FEBICO遠東生技 · NuGene Pharma (Shandong) Co., Ltd. · LEILI MARINEBIO · Qingdao AlgaeNutra Biotech -High Quality Spirulina and Chlorella Factory · Shandong Freda Biotechnology Co.,Ltd
公司信息
注册编号
- Unified Social Credit Code: 914201007646299848
来源: q.stock.sohu.com
核心运营指标与商业动态汇编自企业年报、行业披露及公开工商信息,法定登记编码以主管部门官方登记为准。
身份与联系方式
联系方式、人员和法律信息仅向会员开放。
会员登录